How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Malay essay writing constitutes a critical yet persistently challenging competency for students in Malaysian Independent Chinese Secondary Schools (MICSS), where Mandarin serves as the primary medium ...

The current trajectory of AI development, in which the frontier autonomous systems carry out long and complex tasks under or ...